Mapping the microbiome, food, and human health
Visiting speaker
Phil Strandwitz
Co-Founder, Holobiome Company
Past Talk
In-person
Friday
Dec 13, 2024
Watch video
2:00 pm
EST
Virtual
177 Huntington Ave.
11th floor
11th floor
Devon House
58 St Katharine's Way
London E1W 1LP, UK
58 St Katharine's Way
London E1W 1LP, UK
The microbiome matters for human health, but we largely do not have the tools nor knowledge to change it with any degree of precision for purpose. In this talk, Philip Strandwitz from Holobiome will share some of the approaches Holobiome is taking to enable translation of the field, including building a reference database of over 1,000,000 human gut bacterial genomes, efforts to build a comprehensive collection of all known human gut bacteria, target directed screening to understand which bacteria may matter for human health, and a pipeline to map how food and the microbiome can interface. The goal of this talk is to highlight microbiology and computational capabilities of Holobiome to determine if there may be an opportunity to work together.
About the speaker
About the speaker
Phil is an expert in the field of the human microbiome, with a special focus on the gut-brain-axis. He was supported by one of the first grants in the Human Microbiome Project, and received his PhD in Biology in 2016 at Northeastern University. His graduate work was focused on unraveling the complexities of the human microbiome, resulting in publications in top journals like Nature, Nature Microbiology and Microbiome. He is now CEO and co-founder of Holobiome, a platform biotech company that’s mapping how our microbes impact our biology and developing solutions from that knowledge in the form of consumer products and drugs. He's raised millions in venture financing, secured multiple corporate partnerships (with both food and pharma partners), and won grants the Translational Space Institute for Space Health (TRISH), from the National Institute of Neurological Disease and Stroke, the National Institute of Digestive and Kidney Disorders, among others. He’s also a Termeer Fellow, a mentorship network started by the founding CEO of Genzyme, Henri Termeer. He believes we are here today because of our microbes, and our best future will be empowered by them. of Genzyme, Henri Termeer. He believes we are here today because of our microbes, and our best future will be empowered by them.
Phil is an expert in the field of the human microbiome, with a special focus on the gut-brain-axis. He was supported by one of the first grants in the Human Microbiome Project, and received his PhD in Biology in 2016 at Northeastern University. His graduate work was focused on unraveling the complexities of the human microbiome, resulting in publications in top journals like Nature, Nature Microbiology and Microbiome. He is now CEO and co-founder of Holobiome, a platform biotech company that’s mapping how our microbes impact our biology and developing solutions from that knowledge in the form of consumer products and drugs. He's raised millions in venture financing, secured multiple corporate partnerships (with both food and pharma partners), and won grants the Translational Space Institute for Space Health (TRISH), from the National Institute of Neurological Disease and Stroke, the National Institute of Digestive and Kidney Disorders, among others. He’s also a Termeer Fellow, a mentorship network started by the founding CEO of Genzyme, Henri Termeer. He believes we are here today because of our microbes, and our best future will be empowered by them. of Genzyme, Henri Termeer. He believes we are here today because of our microbes, and our best future will be empowered by them.
Want to be notified about upcoming NetSI events? Sign up for our email list below!
Thank you! You have been added to our email list.
Oops! Something went wrong while submitting the form
